Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma.
作者:
主题词
成年人(Adult);老年人(Aged);抗体, 单克隆(Antibodies, Monoclonal);抗体, 单克隆, 鼠源性(Antibodies, Monoclonal, Murine-Derived);综合疗法(Combined Modality Therapy);女(雌)性(Female);随访研究(Follow-Up Studies);移植物存活(Graft Survival);人类(Humans);输注, 静脉内(Infusions, Intravenous);淋巴瘤, 膜细胞(Lymphoma, Mantle-Cell);男(雄)性(Male);中年人(Middle Aged);脉冲疗法, 药物(Pulse Therapy, Drug);缓解诱导(Remission Induction);回顾性研究(Retrospective Studies);危险性评估(Risk Assessment);疾病严重程度指数(Severity of Illness Index);干细胞移植(Stem Cell Transplantation);存活率(Survival Rate);移植, 自体(Transplantation, Autologous);治疗结果(Treatment Outcome)
DOI
10.1002/cncr.21313
PMID
16104036
发布时间
2015-11-19
- 浏览11

Cancer
1434-41页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文